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Contribution of
Diastolic Vortex Ring to
Left Ventricular FillingWith much interest, we read the recent article by
Martínez-Legazpi et al. (1), which suggests insights
into the role of diastolic vortex formation in ﬁlling of
the left ventricle. We are delighted to see that ﬂuid
dynamics is increasing its presence in the clinical
cardiology community and contributes to animproved understanding of cardiac function as
underlined in the editorial comment (2).
The article by Martínez-Legazpi et al. (1) introduces
a technique to evaluate the contribution of the left
ventricular (LV) vortex to diastolic ﬁlling using
intraventricular velocity estimated by 2-dimensional
color Doppler echocardiography. They aimed to
quantify the percentage of diastolic ﬁlling volume
related to the LV vortex and tried to distinguish
between normal and abnormal LV function. Their
method is based on dividing the intraventricular ve-
locity ﬁeld into 2 components where one is the rota-
tional ﬂow, directly related to the presence of the LV
vortex, and the other is irrotational, a mathematical
approach known as Stokes decomposition widely
applied in ﬂuid dynamics.
Accordingly, Martínez-Legazpi et al. (1) ﬁrst iso-
lated the LV vortex and subsequently tried to adjust
the corresponding velocity to account for the presence
of the LV wall and mitral leaﬂets. Based also on the
communication that we had with some of the authors,
we understood that the method is initiated by
computing the rotational velocity under the assump-
tion that the LV wall is rigid, which should yield a zero
volume for transmitral inﬂow. However, this results in
an estimate of a new transmitral inﬂow volume that is
nonzero. Then the method repeats the same proce-
dure that always results in an inﬂow volume that is
different from the expansion volume, and this process
continues until the solution converges to a value.
One major concern with this method is that once
the LV wall is assumed to be rigid and the ventricle is
full of blood, it is physically impossible to achieve a
nonzero transmitral inﬂow volume. Similarly, when
the LV wall expands, its volume increase cannot
differ from the transmitral inﬂow volume. The fact
that these volumes differ during the individual iter-
ative steps is a direct violation of the fundamental
law of the conservation of mass, and reveals a ques-
tionable calculation in their method. This ﬂaw calls
into question the study’s methodology and subse-
quent results.
Moreover, according to the ﬂuid dynamics con-
servation laws, the role of the LV vortex in diastolic
ﬁlling volume cannot be evaluated merely by volu-
metric balances, but needs to be considered in
conjunction with the corresponding momentum
balances and intraventricular pressure gradients.
Here, the second controversial notion introduced by
Martínez-Legazpi et al. (1) stems from the decompo-
sition of the pressure gradient into a rotational and an
irrotational component. The analysis did not take into
consideration that every gradient ﬁeld is a conserva-
tive ﬁeld by deﬁnition; hence, it has no rotational
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presented in their analysis is rather improper for ﬂuid
dynamics, and we do not believe that it should be
used for such a purpose.
In conclusion, this letter aims to bring attention to
the analyses reported by Martínez-Legazpi et al. (1)
and the supporting editorial views on the article (2).
Although the concerns raised here are highly tech-
nical, we believe that they may have an impact on the
validity of the reported methodology and results, and
consequently, their clinical implications. We hope
that the present letter clariﬁes these technical, albeit
fundamentally signiﬁcant, points on this published
study (1).Gianni Pedrizzetti, PhD
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Contribution of Diastolic Vortex Ring to
Left Ventricular FillingWe read with great interest the letter by Pedrizzetti
and colleagues Because our study (1) has raised some
concerns among these investigators, here we are
pleased to reassure the readers of JACC about the
validity of our ﬁndings.
The impact of a vortex on the intraventricular ﬂow
is conditioned by its effects on the chamber’s wall
movements, which cannot be predicted a priori
without considering the mechanical properties of
the walls and the momentum exchange between the
walls and the ﬂuid. It is true that uncoupling these
effects from the rest of the ﬂow is a challenging taskthat must be accomplished while enforcing ﬂuid dy-
namics conservation laws. We were aware of this
issue from the very onset of our study design. Thus,
we deﬁned that a fraction of wall velocity is caused by
the vortex. This fraction was entered as a single free
parameter (lambda, in our Online Appendix) in our
calculations.
Making use of a novel iterative method, we upda-
ted lambda until mass conservation was ensured.
Brieﬂy, we started the calculation of the vortex ﬂow
with the assumption of rigid walls and thus null
lambda. This resulted in values of ﬂow velocity be-
tween the tips of the mitral valve, which were not
null. Inﬂow volume was measured by time inte-
grating this localized velocity under a 1-dimensional
ﬂow assumption. Note that this 1-dimensional ap-
proximation has been routinely used by the authors
of the letter (2,3) and by others (4) for measuring
inﬂow and has provided important new insight
into left ventricular physiology. Finally, we updated
lambda and repeated the procedure until the new
transmitral inﬂow volume matched the expansion
volume dictated by lambda. Importantly, conver-
gence was achieved in fewer than 5 iterations in all
cases. Furthermore, convergence to the same value of
lambda was achieved regardless of the initial as-
sumption about wall motion (i.e., the same result was
obtained for any initial value of lambda), and the
measured inﬂow volume was only slightly altered by
the change in boundary conditions.
By using this method we were able to demonstrate
some of the physiological implications of intraven-
tricular vorticity in a clinical scenario using clinical
measurements. This was one of the major strengths of
our paper, as emphasized by the reviewers and the
accompanying editorial (5).
Regarding the second concern of Pedrizzetti and
colleagues, which related to the conservation of
momentum, we estimated the rotational velocity ﬁeld
directly from the measured velocity ﬁeld. The latter is
the result of the balance of ﬂuid momentum pressure
and the ﬂuid-structure interaction with the ventric-
ular walls. It is from the resultant velocities that we
reconstructed the pressure gradient ﬁelds and not
vice versa. This approach has also been used before
by the authors of the letter to the editor (3).
Thus, no physical law was inappropriately used in
our study. Although the numerical values reported
are approximate, we would like to reinforce the val-
idity of our results and their clinical implications.Pablo Martínez-Legazpi, MEng, PhD
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